Medicine News and Research

RSS

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

Research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows that an intervention to reduce over-dispensing and waste of asthma medications can succeed without compromising patient safety and can result in substantial cost savings.

13 Nov 2009

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

CMS approves FDG PET for initial staging of cervical cancer

SNM applauds the Centers for Medicare & Medicaid Services- (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions.

13 Nov 2009

Mouth: A diagnostic indicator for general health

The mouth or oral cavity area is an excellent indicator of the whole body's health, says Mao, who is the chair of the new Department of Oncology and Diagnostic Sciences at the School.

13 Nov 2009

EDDA Technology recieves CE Mark for its IQQA-Liver advanced clinical application

EDDA Technology today announced the completion of CE mark for its new release of IQQA®-Liver, an advanced clinical application designed to enhance efficiency and precision in liver imaging evaluation and treatment planning.

13 Nov 2009

George W. Bush Institute to include global health focus; University of California system launches Global Health Institute

Former President George W. Bush will deliver a speech on Thursday marking the launch of the "George W. Bush Institute as a forum for study and advocacy in four main areas: education, global health, human freedom and economic growth," the New York Times writes.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

IVF Witness uses RFID to identify the sperm and eggs, and reduces the risk of lab errors in infertility treatment

A new software technology is helping to reduce the risk of laboratory errors in infertility treatment, by electronically identifying the sperm, eggs, resulting embryos and other materials used in in vitro fertilization (IVF) treatment cycles. Using non-invasive Radio Frequency Identification (RFID), IVF Witness(TM) can track a patient's sperm, eggs and embryos during the course of treatment. If the wrong material is introduced in the lab environment, IVF Witness alerts the staff, via visual and audible signals, to help prevent mislabeling of any materials.

12 Nov 2009

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).

12 Nov 2009

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.

12 Nov 2009

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has announced that two of its studies regarding its application in oncology drug development and personalized medicine have been selected for a poster and oral presentation at the upcoming AACR-EORTC conference in Boston.

12 Nov 2009

Will the health bill bend costs?

One cause for health reform anxiety is that no one is sure whether the legislation would achieve one of its most critical goals: lowering health care costs.

12 Nov 2009

Childhood exposure to environmental pollutants could impact development in the long-term

Children who eat fish more than 3 times per week show a worse performance in the general cognitive, executive and perceptual-manipulative areas. Those with higher levels of exposure to mercury show a generalised delay in cognitive, memory and verbal areas. Mercury is a contaminant found especially in oily fish and canned fish and to a lesser extent in white fish.

12 Nov 2009

New Cat B 750 FAST imaging agent launched by VisEn Medical

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.

12 Nov 2009

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.

12 Nov 2009

Novadaq announces financial results for the third quarter of 2009

Novadaq® Technologies Inc., a developer of real-time imaging systems for use in the operating room, today announced 2009 third quarter revenues of $1,723,000 compared to revenue of $3,311,000 in third quarter 2008. In accordance with corporate policy, a previously reported order in excess of $2,000,000 has not been recorded in sales due to cash not yet received.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Detailed review findings of EMPOWER study to evaluate the Maestro System released

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced preliminary findings from its ongoing detailed review of its EMPOWER™ study, a randomized, double-blind, controlled pivotal study designed to evaluate the safety and efficacy of the Maestro® System in the treatment of obesity.

12 Nov 2009

"Doctors Speak Out" series to discuss today's health issues

How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today’s most pressing health issues.

12 Nov 2009

Frequent heartburn is painful and impacts the quality of life: Study

While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.

12 Nov 2009

Medicine News and Research

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

LA BioMed to participate in a national study of the effectiveness of testosterone

CMS approves FDG PET for initial staging of cervical cancer

Mouth: A diagnostic indicator for general health

EDDA Technology recieves CE Mark for its IQQA-Liver advanced clinical application

George W. Bush Institute to include global health focus; University of California system launches Global Health Institute

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

IVF Witness uses RFID to identify the sperm and eggs, and reduces the risk of lab errors in infertility treatment

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Will the health bill bend costs?

Childhood exposure to environmental pollutants could impact development in the long-term

New Cat B 750 FAST imaging agent launched by VisEn Medical

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

Novadaq announces financial results for the third quarter of 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Detailed review findings of EMPOWER study to evaluate the Maestro System released

"Doctors Speak Out" series to discuss today's health issues

Frequent heartburn is painful and impacts the quality of life: Study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News